Effectively & Efficiently Structuring Deals as Small Neuroscience Companies

2:00 pm - Wednesday 29th April 2026

  • Discussing the panel’s experience executing and performing due diligence across neuroscience deals – what are the learnings from having partnerships with pharma?
  • Discussing how to get proof of concept earlier to secure additional investment or partnership
  • Outlining opportunities for creative deal structures, and when and where they would be appropriate

Speakers:

Co-founder & Senior Director Corporate Development
Aliada Therapeutics
Business Development Advisor
Phrenix Therapeutics
Principal, Company Creation
Frazier Life Sciences
Head of BD&L Transactions Neuroscience
Novartis
President & Chief Financial Officer
Neurogene Inc.